Phase IV Documentation Translation
Do you require on-demand language support for your phase IV documentation? Phase IV studies, also known as postmarketing surveillance, provide additional information about a pharmaceutical drug’s safety and efficacy.
Pharmaceutical companies and CROs increasingly require translation and review services to meet ongoing international regulatory requirements, to conduct additional safety tests and for compelling business reasons. Responsive Translation is trusted by the leading names in the pharmaceutical industry for fast, accurate and efficient foreign-language services in clinical trial research and postmarketing monitoring.
Clinical Trial Service Specialists
For more than three decades, Responsive Translation has been providing these kinds of services to clients like Merck, Pfizer, Bristol-Myers Squibb, Johnson & Johnson and Sanyo Pharma, who value our expertise, quality and experience.
Dedicated to compliance-intensive industries, Responsive Translation specializes in clinical trial translation and validation services. We recruit and continuously train a network of highly-qualified clinical translators and medical specialist subject matter experts. Together with our custom workflows and advanced terminology management, we work up to 60% faster than agency competitors to bring our clients work that is guaranteed for quality.
Responsive Translation provides ISO 9001 certified services using stringent quality assurance processes. Not only do we use teams of knowledgeable translators, thorough editors and eagle-eyed proofreaders who are carefully selected for their qualifications and suitability for the project at hand, but we provide a range of additional review services that act as safety valves to achieve the perfect, defensible translation. This includes cognitive debriefing, linguistic validation and compliance review.
Next Steps
To discuss your requirements for phase IV documentation translation, or to receive more information on Responsive Translation’s range of clinical translation and review services, please contact us at +1-212-818-1102 or [email protected].